• Intelligent Bio Solutions remains on track for a 2025 U.S. launch of its non-invasive Intelligent Fingerprinting Drug Screening System.
• The company’s FDA 510(k) submission included validation studies showing 94.1% accuracy in detecting opiates through fingerprint sweat.
• INBS is already active in 24 countries, with over 450 commercial accounts globally, and adoption growing across diverse industries, including logistics, mining, retail, and marine operations.
• The firm is expanding its distributor network to support localized growth ahead of its U.S. market entry.

Intelligent Bio Solutions (NASDAQ: INBS), a medical technology company specializing in rapid, non-invasive testing solutions, is preparing for its expected U.S. launch in 2025, as it is progressing through the FDA clearance process for its Intelligent Fingerprinting Drug Screening System. The non-invasive device, which detects recent drug use via fingerprint sweat, is gaining international traction for its speed, portability, and ability to integrate into a range of safety-critical environments.

On Dec. 18, 2024, INBS submitted a 510(k) premarket notification to the U.S. Food and Drug Administration, seeking clearance for its opiate test system for codeine (https://ibn.fm/YVRNE). The FDA classified the system as a Class II medical device, which requires this form of submission. As of March 2025, the FDA has issued an Additional Information (“AI”) request, a standard part of the review process that pauses the 90-day review clock while the company prepares its response.

The 510(k) filing includes data from method comparison and pharmacokinetic studies. INBS reported a 94.1% accuracy rate in its performance evaluations and emphasized that fingerprint sweat provides a viable and statistically consistent alternative to blood for drug detection. According to the company, these findings support its plans to launch the platform in the U.S. and expand the system’s testing panel to additional drug classes over time.

“We appreciate the thoroughness of the FDA’s process, which aligns with our expectations. As we await FDA clearance, we remain confident in the strength of our data, which demonstrates the accuracy, reliability, and usability of our technology,” said Harry Simeonidis, President and CEO of INBS. “We are actively preparing for our planned U.S. launch in 2025, where we see significant opportunities to revolutionize drug screening with our non-invasive, rapid testing solution.”

Outside the U.S., INBS continues to expand its commercial footprint, reflecting rising global demand for drug screening technologies that can deliver fast, reliable results without the logistical challenges of traditional methods. As of May 2025, the company reported more than 450 active accounts across 24 countries, with 35 new clients added in the third fiscal quarter alone (https://ibn.fm/CgnKV).

Growth is being driven by industries where on-site, rapid testing is critical. INBS has seen adoption in sectors including transportation, engineering, logistics, mining, and, most recently, luxury marine operations in Europe. In Australia, the technology has gained traction in remote testing programs, waste management, and retail, including implementation by a major e-commerce brand.

To support expansion, INBS is building out its distributor network, which now spans 19 countries through 18 regional partners. The company is also preparing to offer collected testing services, aimed at organizations that require centralized testing capacity for high volumes.

The fingerprint-based screening system delivers results in under ten minutes and does not require specialist medical personnel to administer. This ease of use, combined with its compact form factor and accuracy, makes it attractive to organizations managing distributed or mobile workforces.

Doug Heath, INBS’s Vice President of Global Sales, said the technology is resonating with clients seeking a simpler and faster alternative to traditional urine or saliva tests. “Traditional testing methods aren’t keeping up with operational demands – our solution is,” Heath said. “Industries are moving quickly to adopt a system that’s fast, diverse in its capabilities, and easy to implement.”

For more information, visit the company’s website at https://ibs.inc.

NOTE TO INVESTORS: The latest news and updates relating to INBS are available in the company’s newsroom at https://ibn.fm/INBS

• Recent interviews with ESGold Corp. officers highlight the company’s strategy to build revenue through clean technology mine tailings reclamation that will build into an exploration project at a legacy site in Quebec
• Officers for the Canada-based gold and silver development company have presented investor updates on ESGold’s timeline for production in a variety of forums and interviews, most recently at Canada’s Metals Investor Forum
• ESGold’s Montauban Gold-Silver Project covers 265 mining claims across 13,116 hectares (about 32,410 acres) in Quebec, where the project site was mined for 90 years, and company officers say there is still more potential gold and silver at depth in a VMS structure
• The company anticipates beginning production on the tailings reclamation by year-end and working that for three years before expanding its operation

Pre-production gold and silver resource developer ESGold (CSE: ESAU) (OTCQB: ESAUF) has a positive outlook for the precious metals as company officers promote insights to its unique clean extraction model and revenue strategy, which is focused on its permitted asset in a Quebec historic resource.

“We’re totally different than every other junior resource company. We’re here to make money as well, and what we’re doing … first is going into production, and then doing our exploration,” ESGold President and Director Brad Kitchen said during a presentation at this month’s Metals Investor Forum in Vancouver (https://ibn.fm/I55Tr). “Basically, what we’re going to be doing is processing tailings, extracting silver and gold and mica. … And those tailings will bring in a revenue of about $35 million a year. That revenue will then help fund exploration. We’re not going to have to go to the market.”

Kitchen noted that most junior gold and silver resource companies begin by exploring a site and expanding once a feasibility study may help them move decisively toward production, but then prohibitive costs and other dilutive factors cause the companies’ values to drop off, creating a frustrating obstacle.

“So what you’re doing (with ESGold) is you’re combining the upside on the exploration plus the upside on the production, and there’s no downside,” he said.

The company will go into production before the end of the year at its Montauban Gold-Silver Project, which covers 265 mining claims across 13,116 hectares (about 32,410 acres).

“In any sort of mining project, the toughest thing to is to get the permits and then also get the community behind you,” Kitchen said. “So, (CEO and Director Paul Mastantuono) was able to do that and that allows us to go into production, literally as soon as Halloween.”

Total gold demand reached a record annual high last year as it continued to rebound in the wake of the COVID pandemic, according to the World Gold Council (https://ibn.fm/JwTec). Amid economic volatility during the first months of this year, gold’s appeal has continued to grow, with prices briefly touching $3,500 last month when anxiety over the United States’ trade tariff and interest rate policies reached a peak level (https://ibn.fm/7kjgw).

“I’m very bullish on gold and silver,” Kitchen told Canadian junior stock market investment podcast The Deep Dive at the time (https://ibn.fm/nXlnU). “Just in the fact that, with silver especially, you’re going to have to have that resource to help with all the electric vehicles, all the solar panels. But with gold itself, it still is that safe base. People still look at it as something that they can see tangible value.”

High-conviction silver investor Peter Krauth invited ESGold to present at the Metals Investor Forum and has identified ESGold as a standout story among junior gold-silver companies advancing toward production, underscoring the market interest in ESGold’s potential, according to a company news release (https://ibn.fm/gnxqc).

“About nine months ago, the company … had a $3 million market cap. It was trading maybe 5,000 to 10,000 shares a day,” Kitchen said during the Metals Investor presentation. “We’re now at $35 million market cap nine months from there. We’re trading about 250,00 to 300,000 shares a day. We’ve raised $5 million. All of that money has come from friends, family and some specific family trusts. So we haven’t gone to the brokerage community, we haven’t hit the institutional market yet.”

For more information, visit the company’s website at https://esgold.com.

NOTE TO INVESTORS: The latest news and updates relating to ESAUF are available in the company’s newsroom at https://ibn.fm/ESAUF

• AVERSA Fentanyl has potential to become the world’s first opioid pain patch with abuse deterrent properties, CEO states in report
• Nutriband and Kindeva Drug Delivery have formalized a strong product-development partnership and long-term commitment
• Other key steps outlined as company works to develop, scale-up manufacturing process to bring Aversa technology closer toward commercialization

In a recent report to shareholders, Nutriband (NASDAQ: NTRB) CEO Gareth Sheridan shared significant company achievements and milestones as well as his expectations for 2025 (https://ibn.fm/9K5zT). At the center of the company’s positive outlook for future is noteworthy progress made toward the commercialization of its proprietary Aversa technology, including a strong partnership with Kindeva Drug Delivery.

“Nutriband is primarily focused on working with our partner Kindeva Drug Delivery, a leading global contract development and manufacturing organization focused on drug-device combination products, to develop our lead product, AVERSA(TM) Fentanyl, which incorporates Nutriband’s AVERSA abuse-deterrent transdermal technology into Kindeva’s FDA-approved transdermal fentanyl patch,” stated Sheridan in the letter.

“AVERSA Fentanyl has the potential to become the world’s first opioid pain patch with abuse deterrent properties and is estimated to potentially reach peak annual sales of $80 million–$200 million,” he continued. “In addition, AVERSA Buprenorphine, our next candidate for AVERSA, is projected to reach peak annual sales of $70 million–$130 million. Nutriband recently performed an extensive evaluation of the commercial cost of goods of incorporating the AVERSA technology into existing FDA-approved transdermal patches and has confirmed the viability of achieving high margins that are typically found in NDA pharmaceutical products.”

Sheridan noted that Nutriband and Kindeva have formalized an exclusive product-development partnership and long-term commitment based on shared development costs in exchange for milestone payments. This agreement “solidifies a transition to commercial scale development for AVERSA(TM) Fentanyl,” he noted.

“We have confidently shifted our focus from feasibility towards commercial development in support of an NDA filing and commercialization,” Sheridan observed. “This was a very strong show of support from our partner Kindeva, which also allowed us to reduce the impact of dilution to our existing shareholders, which I stress has been and will remain a core focus of the company. This was evident through our raise of $8.4 million in April 2024 in a nonbrokered private placement primarily through existing shareholders.”

In addition to the company’s partnership with Kindeva, Sheridan noted other key steps taken as Nutriband works to develop and scale-up the manufacturing process to bring Aversa technology closer toward commercialization. Those steps have included developing and refining Nutriband’s proprietary technology for commercial scale manufacturability, establishing the commercial supply chain and validating the analytical methods required to meet U.S. Food and Drug Administration (“FDA”) regulatory standards for a pharmaceutical product.

Nutriband has also expanded the worldwide intellectual property portfolio for its AVERSA abuse deterrent technology, the shareholder report noted. That expansion has included approvals in China and its territories, Hong Kong and Macao, as well as a new patent approval in the United States.

“This improves our position to bring our leading abuse deterrent platform to market,” Sheridan explained. “We are now patented in 46 countries around the world. While initially concentrating on the U.S. market, the unmet medical need for adequate pain management is a global problem, and our goal is to make a global solution strategically targeting all major medical markets in the world.”

In the report, Sheridan outlined the company’s “ambitious yet achievable” 2025 goals. Nutriband will work on getting into the clinic to evaluate its lead product, AVERSA(TM) Fentanyl, in a pivotal Human Abuse Liability (“HAL”) clinical trial, which be key for an NDA filing. This will involve manufacturing clinical supplies using a commercial scale process as well as filing an Investigational New Drug application with the FDA. The company is also exploring new potential international partnerships for its AVERSA intellectual property and will be evaluating licensing and partnership opportunities, all while working to have the AVERSA(TM) Fentanyl product to be used in mass soon.

Sheridan also pointed out the strong revenue numbers reported by Nutriband’s Pocono Pharma subsidiary for its kinesiology tape contract manufacturing services. Company officials believe that 2025 is shaping up to be Pocono Pharma’s best year on record due to its expanding manufacturing collaboration with KT Tape, the world leader in kinesiology tape.

“Many of you have been with us from the beginning,” Sheridan concluded. “And many more joined our mission to change the pharmaceutical industry for the better by developing our AVERSA technology designed to improve the safety of easily abused transdermal drugs, such as pain medications, while making them available to patients who need them. Pain patients have been struggling with inadequate care for too long, and they deserve to be able to access the medication they need. AVERSA gives them this access. Today we are on track to be the world’s first and only abuse deterrent technology in the transdermal space targeting abusable medications such as fentanyl and buprenorphine.”

For more information, visit the company’s website at www.Nutriband.com.

NOTE TO INVESTORS: The latest news and updates relating to NTRB are available in the company’s newsroom at https://ibn.fm/NTRB

• FAVO Capital is developing a digital lending platform tailored to small and medium-sized businesses, targeting gaps left by traditional banks
• Proprietary fintech tools and flexible financing solutions aim to provide capital access for businesses that are often denied by legacy lenders
• Rising demand for alternative credit sources presents a major opportunity for agile, tech-driven lenders like FAVO

With over 5.5 million new business applications filed in the U.S. last year alone, small- to medium-sized businesses (“SMBs”) are thriving, but many are finding themselves underserved by traditional financial institutions. According to recent industry insights, 6 in 10 SMBs are denied access to essential funding due to outdated underwriting processes that fail to reflect their real financial health.

This growing disconnect has paved the way for fintech innovators to step in with more inclusive, tech-enabled lending models. Among these players is FAVO Capital (OTC: FAVO), a company focused on delivering fast, flexible, and accessible capital solutions for SMBs that are often overlooked by banks.

Proprietary Technology to Modernize SMB Financing

FAVO Capital is currently developing a proprietary lending platform and mobile app designed to streamline the funding process for business owners. Once launched, this digital ecosystem will allow clients to apply for funding, track their progress, and manage repayments through a user-friendly interface.

In parallel, the company is exploring the integration of advanced analytics and alternative data sources into its credit decision-making. By evaluating factors like cash flow, vendor payment behavior, and transaction histories, FAVO aims to provide more predictive, fairer assessments of creditworthiness, especially for businesses that may not have an established credit file.

Flexible Products for Real-World Business Needs

FAVO Capital doesn’t rely on one-size-fits-all products. Instead, it structures customized capital solutions that evolve alongside its clients’ needs. Whether it’s short-term working capital or a longer-term growth initiative, the company’s financing products are designed to be adaptive, helping business owners overcome real-world financial hurdles.

This kind of lending agility is especially valuable for low-revenue or newly formed SMBs, many of which require loans of $100,000 or less, an amount most traditional banks don’t prioritize.

A Market Ready for Disruption

With SMBs representing 99.9% of all American businesses and contributing roughly 40% of U.S. GDP, the need for modern funding solutions is not only massive but urgent. As traditional credit models struggle to meet the diverse and fast-moving demands of small businesses, companies like FAVO Capital are positioned to gain traction.

By leveraging fintech tools, proprietary platforms, and a customer-first approach, FAVO Capital could play a vital role in transforming how American small businesses access the capital they need to grow, compete, and thrive.

For more information, visit the company’s website at FAVOCapital.com.

NOTE TO INVESTORS: The latest news and updates relating to FAVO are available in the company’s newsroom at https://ibn.fm/FAVO

• The Santa Fe Mine hosts 1.95 million ounces of pit-constrained gold equivalent resources across Indicated and Inferred categories.
• A 2025 Preliminary Economic Assessment for Santa Fe outlines an after-tax NPV5% of $200 million and a 34.2% IRR based on spot pricing.
• All four projects are 100%-owned or under low-cost acquisition agreements, with development centered in Nevada, the world’s top mining jurisdiction.
• Near-term catalysts include Santa Fe permitting milestones, West Santa Fe’s maiden drill program, and an updated economic study.
• The company is led by a proven team with multiple M&A exits and extensive experience in advancing heap-leach gold operations.

Lahontan (TSX.V: LG) (OTCQB: LGCXF) is a Canadian mine development and exploration company advancing a portfolio of gold and silver assets in Nevada’s Walker Lane, one of the world’s most productive and mining-friendly regions. Through its U.S. subsidiaries, the company controls four gold and silver properties in Nevada, three of which are 100%-owned and one under a low-cost option to acquire full ownership. With a clear near-term path to production, Lahontan is focused on unlocking oxide gold and silver value from past-producing, infrastructure-ready projects.

The company’s mission is to responsibly develop and expand its oxide resources while minimizing capital intensity and maximizing economic returns. Leveraging a strong technical team with a track record of advancing high-margin heap-leach operations, Lahontan is progressing both resource growth and permitting milestones across multiple sites. Its strategy prioritizes scalability, efficiency, and timely value realization for shareholders.

By maintaining full project ownership and a capital-light development model, Lahontan Gold is positioned to rapidly transition from development to production.

The company is headquartered in Toronto, Ontario.

Projects

Santa Fe Mine

The 26.4 km² Santa Fe Mine is Lahontan’s flagship asset and core development priority. A past-producing open-pit, heap-leach gold and silver operation, Santa Fe historically yielded more than 359,000 ounces of gold and 702,000 ounces of silver between 1988 and 1995. The site benefits from established infrastructure—including power, water, and road access—and more than 79% of its known resources are unencumbered by royalties.

A 2024 NI 43-101 resource estimate outlines 1.54 million ounces of gold equivalent (“AuEq”) in the Indicated category and 0.41 million ounces Inferred, all pit-constrained. Oxide resources average among the highest grades in the state and are distributed across five known deposits. A 2025 Preliminary Economic Assessment (“PEA”) projects strong economic returns, including an after-tax NPV5% of $200 million, a 34.2% internal rate of return (“IRR”), and average annual production of approximately 50,000 ounces AuEq over an eight-year mine life.

Permitting is well underway for both the Exploration and Mine Plans of Operation, covering over 12 km² and more than 700 drill holes. The company is targeting construction readiness in 2026 and continues to pursue oxide resource expansion and metallurgical optimization, particularly within the Slab-Calvada corridor.

West Santa Fe

West Santa Fe lies just 13 kilometers from the flagship and is being explored as a potential satellite operation. The project is defined by a shallow, oxide-dominant gold-silver system with a conceptual target of 0.5 to 1.0 million ounces AuEq based on historic drilling and recent surface sampling, which returned up to 2.61 g/t Au and 899 g/t Ag (14.6 g/t AuEq). A 6,300-meter Phase One reverse circulation drill program is scheduled for 2025 to validate historical data and support a maiden resource estimate. Development is streamlined under a low-cost option agreement and a rapid permitting path via Notice of Intent.

Moho and Redlich

The Moho and Redlich projects provide additional longer-term upside within Lahontan’s portfolio. Moho features high-grade, oxidized epithermal veins with historic production at grades of 20–25 g/t Au and 300 g/t Ag. A 2019 core drill program confirmed the presence of high-grade mineralization at depth. Redlich, located along trend from the historic Candelaria silver mine, hosts disseminated Ag mineralization in epithermal veins and hydrothermal breccias but remains untested by drilling. While no near-term programs are currently disclosed, both assets represent future exploration optionality.

Market Opportunity

Lahontan Gold operates in Nevada, consistently ranked the top global mining jurisdiction by the Fraser Institute due to its transparent permitting process, legal stability, and established infrastructure. Nevada produces over 4.5 million ounces of gold annually, generating approximately $9 billion in value, and ranks fifth globally in total gold production.

According to the World Gold Council, total gold demand in Q1 2025 reached 1,206 tonnes, up 1% year-over-year, marking the strongest first quarter since 2016. Central banks added 244 tonnes to reserves, a slight slowdown from the prior quarter but well within the strong buying range observed over the past three years. Meanwhile, silver demand is supported by strong industrial usage in solar panels, electric vehicles, and semiconductors, with long-term deficits forecast in the physical silver market.

With macro-driven demand for gold, technology-driven silver consumption, and strong institutional buying across both metals, Lahontan is uniquely positioned to capitalize through its portfolio of oxide-focused projects in a top-tier jurisdiction—offering near-term production potential and longer-term resource expansion.

Leadership Team

Kimberly Ann, Founder, CEO, President & Executive Chair, is a veteran mining executive with a track record of founding and scaling junior resource companies. She has raised over $210M in financing and led the $340M buyout of Prodigy Gold. Her prior roles include CFO of PPX Mining and founder of Latin America Resource Group, which merged with Carube Copper to form C3 Metals.

Brian Maher, Founder and VP of Exploration, is an economic geologist with more than 45 years of experience. He previously led Prodigy Gold as CEO, where he helped develop the Magino gold project before its $341M acquisition. His career includes senior roles at ASARCO, Hochschild Mining, and PPX Mining, where he oversaw exploration and production in the Americas.

John McNeice, Chief Financial Officer, is a Chartered Professional Accountant with three decades of experience in public company reporting. He has served as CFO for seven public resource companies and played a key role in Ur-Energy Inc.’s TSX IPO and $150M in financings. He also serves as CFO for Gold79 Mines, C3 Metals, and Northern Graphite Corp.

For more information, visit the company’s website at https://lahontangoldcorp.com.

NOTE TO INVESTORS: The latest news and updates relating to LGCXF are available in the company’s newsroom at https://ibn.fm/LGCXF

• ONAR’s acquisition-led growth operation is accelerating, with a major marketing tech acquisition set to double revenues at subsidiary Storia
• AI, data, and automation are at the core of ONAR’s efforts to help middle-market clients achieve measurable marketing performance
• Fiscal 2024 marked major operational progress, with asset growth, cost reduction, and increasing investor confidence through successful capital raises

Marketing in the Age of AI and Data

Marketing is undergoing a once-in-a-generation transformation, powered by artificial intelligence, real-time data, and next-generation automation. Today’s marketing systems aren’t static; they’re dynamic, adaptive, and personalized in real time. For growth-stage and middle-market businesses, this shift presents both a challenge and an opportunity. Navigating this landscape requires tools that are flexible, insights that are deep, and strategies grounded in data. That’s precisely where ONAR Holding Corp. (OTCQB: ONAR) is establishing itself as a market leader.

Founded in 2021, ONAR is operating a network of best-in-class, technology-first marketing agencies designed to scale client performance in the digital age. By acquiring and integrating high-performing agencies into its operations, ONAR is offering clients measurable outcomes through proprietary tech, AI-powered workflows, and creative storytelling, an essential blend in the emerging “intelligence economy” of marketing.

A Transformative 2024 Sets the Stage

According to its April 2025 shareholder letter, ONAR achieved meaningful financial and operational growth last year. The company increased total assets by $1 million year-over-year to approximately $2.45 million and closed 2024 with nearly $1 million in current assets, marking key indicators of rising business momentum. Despite ending the year with a net loss, largely attributable to the costs tied to its reverse merger and ongoing transformation, ONAR has taken active steps to strengthen its financial position.

Cost-cutting measures reduced cost of revenues by $250,000 year-over-year, while capital raising efforts brought in about $2.1 million in notes payable during the year. Much of this capital is now being converted to equity, reflecting investor confidence in ONAR’s long-term strategy and helping to improve the company’s balance sheet.

Additionally, management reports that it is in late-stage conversations to finalize a new financing round, which will support its next acquisition and fuel further expansion.

Strategic Acquisitions Driving Growth

Central to ONAR’s growth plan is its disciplined roll-up strategy: acquiring innovative martech firms that complement its existing portfolio and unlock synergy opportunities. In February 2025, ONAR announced it would acquire a high-performing marketing technology company to merge with its subsidiary Storia. Once closed, this transaction is expected to double Storia’s revenues and drive stronger EBITDA margins through tech integration and operational efficiencies.

The acquisition reflects ONAR’s broader vision: to assemble a network of best-in-class agencies that leverage technology and combine data science, creative strategy, and performance marketing under one agile, scalable platform. By embedding proprietary AI across campaign workflows, ONAR agencies deliver dynamic personalization, predictive targeting, and automation that enhances every customer touchpoint.

A $1.7 Trillion Opportunity

ONAR’s vision is set against the backdrop of a rapidly expanding global martech market. According to Coherent Market Insights, the global marketing technology market is projected to nearly triple from $575.11 billion in 2025 to $1.77 trillion by 2032, representing a 17.3% CAGR. This explosive growth is being fueled by the increasing demand for AI-powered marketing tools, automation platforms, and data-driven engagement across industries such as retail, e-commerce, finance, and healthcare.

Automation tools are expected to make up over a third of total market share in 2025, with North America leading in overall spending and Asia Pacific posting the fastest growth. For companies like ONAR, focused on deploying intelligent, scalable solutions for mid-sized businesses, the timing couldn’t be better. As digital transformation accelerates and traditional marketing tactics lose effectiveness, businesses are increasingly seeking measurable performance from their marketing spend – precisely what ONAR’s agencies deliver.

While regulatory complexity and cost remain barriers to entry for smaller players, ONAR’s model and capital access give it a competitive edge in navigating these challenges and capturing share in one of the fastest-growing segments of the digital economy.

Poised for What’s Next

With its acquisition strategy accelerating, core financials improving, and investor support growing, ONAR is positioning itself as a force in the modern marketing ecosystem. The company’s leadership is building toward a future where data, technology, and storytelling converge to transform how brands engage customers.

For investors seeking exposure to the digital marketing space, particularly those targeting middle-market growth, ONAR offers a compelling value proposition at the intersection of martech innovation and acquisition-driven scalability.

For more information, visit the company’s website at www.ONAR.com.

NOTE TO INVESTORS: The latest news and updates relating to ONAR are available in the company’s newsroom at https://ibn.fm/ONAR

• Sports investing is emerging as a recognized alternative asset class, attracting institutional capital.
• Media rights, digital expansion, and global fan engagement are driving up sports asset valuations, with the sector expected to surpass $700 billion in value by 2030.
• Brera focuses on sustainable football investment in growth-stage clubs rather than high-profile acquisitions; the company’s 2023 Nasdaq IPO was the first-ever listing of a multi-club ownership (“MCO”) group.
• A pending $2 billion IPO from Eagle Football Holdings could bring more visibility to the MCO model.

As sports investing gains traction among institutional investors, Brera Holdings (NASDAQ: BREA), a global sports investment group, is positioning itself as a public-market pioneer in the evolving space. With a growing global portfolio of sports clubs and a strategy grounded in sustainability and operational upside, Brera represents an emerging model for investors seeking exposure to professional sports.

Brera’s 2023 IPO on Nasdaq was the first-ever public listing of a multi-club ownership (“MCO”) group, placing it ahead of notable private MCOs like Red Bull, City Football Group, and Qatar Sports Investments. The company focuses on acquiring and developing men’s and women’s sports clubs with strong local roots, investing in infrastructure and professionalizing operations as a foundation for long-term value creation.

The company’s approach stands out in a sports investment landscape that is becoming increasingly attractive to institutional and retail investors alike. According to a recent Goldman Sachs report titled Getting in the Game: The Future of Sports Investing, rising media rights valuations, fan engagement opportunities, and a broader shift toward professionalized management are pushing sports toward becoming a mainstream asset class (https://ibn.fm/g3Gog). The report notes that institutional interest is rising in part due to the growing challenge of individual ownership, encouraging new models of participation and capital access.

Brera’s operations align with this shift. Its investment in Juve Stabia, a soccer club recently promoted to Italy’s Serie B and now contending for a Serie A berth, illustrates how Brera targets clubs with upside potential rather than legacy prestige. By focusing on scalable improvements and sustainable management, the company is aligning its model with what The Wall Street Journal recently described as the increasingly successful approach taken by U.S. investors in European football (https://ibn.fm/Zav7k).

Sports investing is no longer a niche for billionaires. As noted by Financial Content, the industry is projected to surpass $700 billion in value by 2030, driven by media, technology, and the increasing demand for live, unscripted content (https://ibn.fm/i6d56). These dynamics are reshaping how ownership is structured and opening the door for public market investors to gain exposure.

Brera’s strategy also gains relevance in light of recent developments around Eagle Football Holdings, an MCO led by U.S. businessman John Textor. According to City AM and Bloomberg, Eagle Football is preparing a $2 billion IPO, which would be the first large-cap listing of an MCO group (https://ibn.fm/quX11). Textor’s firm holds stakes in high-profile clubs across Europe and South America. Brera welcomed the news, noting that such a listing would bring added visibility to MCOs and further validate sports as a viable asset class.

“We wish John well on his IPO and look forward to the increased investor visibility this potential offering would bring to the MCO sector, as well as sports-as-an-asset-class overall,” said Dan McClory, Executive Chairman of Brera Holdings.

Brera continues to expand globally with a diversified portfolio approach. The company’s structure allows for international diversification, public market governance, and accessibility to investors who may otherwise find professional sports ownership out of reach. This model represents an alternative path to returns in a sector that combines financial performance with cultural relevance and fan engagement.

For more information, visit the company’s website at www.BreraHoldings.com.

NOTE TO INVESTORS: The latest news and updates relating to BREA are available in the company’s newsroom at https://ibn.fm/BREA

• Adageis delivers a user-friendly platform that helps providers identify high-value services while improving care quality.
• The company’s patented ProActive Care Platform leverages AI to shift providers from fee-for-service to value-based care models.
• The system integrates seamlessly with major EHR platforms to enhance operations without disrupting workflows.
• Adageis supports over 260,000 patient lives and expects that figure to more than double by the end of Q2 2025.
• The company is helping providers better understand insurance contract value and advocate for appropriate reimbursement.

For healthcare practices navigating the shift toward value-based care, the complexity of insurance contracts, quality metrics, and data reporting can be a barrier to better outcomes and stronger financial performance. Adageis, a growing healthcare technology company, is offering a unique streamlined and AI-powered software solution designed to make this transition simpler.

At the core of the company’s offering is the ProActive Care Platform, a patented, AI-centric engine that enables providers, health systems, ACOs, and CINs to identify and act on high-value opportunities within their existing operations. What sets Adageis apart is ease of use, giving practices clear, actionable insights on where value lies, and how to pursue it while maintaining or improving quality of care.

The platform has been rebranded as a fintech AI tool, focusing on helping providers navigate reimbursement structures, align with quality metrics, and increase revenue through optimized care.

Adageis’s system is designed to easily pair with existing electronic health record (“EHR”) systems. It is compatible with leading platforms like Epic, Allscripts, Cerner, AthenaHealth, and eClinicalWorks. This flexible integration approach ensures that clinics and providers can onboard without lengthy training or operational disruption.

Through a powerful application programming interface (“API”), the software analyzes patient data to surface value-based care opportunities, identify high-risk individuals, and highlight care gaps. These insights can then be used to prompt more timely interventions, coordinate more efficient care, and reduce avoidable healthcare costs.

A central feature of Adageis’s approach is its Patented Risk Engine (“PRE”), which leverages AI to improve population health management. The system continuously monitors patient data beyond the office visit and provides proactive care suggestions that can reduce emergency room visits, lower hospital admissions, and strengthen patient engagement.

As of April 2025, Adageis supports over 260,000 patient lives and has set ambitious near-term goals. By the end of Q2 2025, the company projects it will cover 580,000 lives, reach $100,000 in monthly recurring revenue, and onboard two to three new clients per month.

Another component of the platform is helping providers understand the full value of their insurance contracts. Adageis positions itself as an advocate for its clients, providing transparency and intelligence on what reimbursements practices should expect when delivering high-quality care. This kind of support can be especially beneficial for smaller organizations that may lack internal resources for revenue optimization.

Adageis is also in ongoing talks with investors to broaden its product offering, with a particular focus on tools tailored to the needs of small practices navigating the shift to value-based models.

For more information, visit the company’s website at www.Adageis.com.

NOTE TO INVESTORS: The latest news and updates relating to Adageis are available in the company’s newsroom at https://ibn.fm/Adageis

• Momentum suggests a positive trajectory in the private credit market in the coming year.
• FAVO Capital offers flexible capital solutions tailored to SMBs’ unique needs.
• The company’s approach exemplifies how private credit firms are leveraging technology to enhance their offerings.

The private credit market is on the cusp of substantial expansion in 2025, driven by a resurgence in global mergers and acquisitions (“M&A”), the digitization of lending processes and the emergence of innovative financing solutions tailored for small and medium-sized businesses (“SMBs”) (https://ibn.fm/pDNA4). This confluence of factors is reshaping the financial landscape, as companies such as FAVO Capital (OTC: FAVO) are strengthening their foothold in the growing space.

“Global M&A is recovering from its 10-year low, as global GDP outperformed expectations and central banks began easing monetary policy,” reported global financial services group Macquarie in a recent report. “Though activity levels remain well below the long-term average, last year deal volumes grew 7%, according to data from Preqin, and values increased 15% to $3.5 trillion, edging the market closer to pre-pandemic levels.” This uptick reflects growing confidence among dealmakers, fueled by improving economic conditions and pent-up demand, the report continued, with Bill Eckmann, head of Principal Finance and Private Credit at Macquarie Capital, emphasizing that while deal flow remains below normalized levels, the momentum suggests a positive trajectory for the coming year.

Parallel to the M&A resurgence, the digitization of lending is significantly transforming small business financing. By integrating new technologies and data into operations, digitization streamlines processes, making lending more accessible and efficient for both lenders and borrowers. This technological shift enhances the speed and accuracy of credit assessments, enabling lenders to better evaluate the creditworthiness of small businesses. Consequently, entrepreneurs benefit from expedited loan approvals and more tailored financing solutions.

However, the adoption of digital lending technologies is not without challenges, according to a recent article from the Bipartisan Policy Center (https://ibn.fm/dzHzF). Concerns regarding data privacy, security risks and the potential for algorithmic biases necessitate careful consideration and regulation. Ensuring that these digital tools are implemented responsibly is crucial to maintain trust and fairness in the lending process.

Amid these industry shifts, private credit firms are stepping up to bridge the financing gap for SMBs. FAVO Capital, for instance, is a rapidly growing private credit company dedicated to providing fast, efficient, and personalized funding solutions for small and medium-sized businesses. Recognizing the challenges businesses face in securing traditional financing, FAVO Capital offers flexible capital solutions tailored to their unique needs.

FAVO Capital has more than $138 million in total funding supporting more than 10,000 businesses. The company leverages artificial intelligence (“AI”)-powered analytics to provide faster, smarter funding decisions. Publicly listed and regulated, FAVO Capital is committed to transparency and investor confidence. The company has expanded its market reach, currently operating in 45 states and the Dominican Republic. FAVO’s fast, flexible financing can result in funding delivered within hours, as it executes on its strategic expertise combined with cutting-edge fintech solutions.

FAVO Capital’s approach exemplifies how private credit firms are leveraging technology to enhance their offerings. By utilizing technology-driven underwriting and alternative financing solutions, the company empowers businesses with the capital they need without the restrictions of traditional lenders. This strategy not only accelerates the funding process but also provides more customized financing options that align with the specific requirements of SMBs.

For more information, visit the company’s website at FAVOCapital.com.

NOTE TO INVESTORS: The latest news and updates relating to FAVO are available in the company’s newsroom at https://ibn.fm/FAVO

• CEO Dr. Richard Lu discussed SolarBank’s vertically integrated business model on a recent GotStocks podcast.
• SolarBank is an expanding developer, builder, operator, and owner of clean energy projects across North America, maintaining a $184 million portfolio of assets generating recurring revenue.
• The company’s flexible supply chain strategy helps mitigate any tariff risks while reducing costs.
• Going forward, a recently announced up to $100 million transaction with CIM Group is set to fund up to 97 MW of U.S. community solar projects.

Disseminated on behalf of SolarBank Corporation

Dr. Richard Lu, CEO of SolarBank (NASDAQ: SUUN) (Cboe CA: SUNN) (FSE: GY2), a premier developer and owner of renewable and clean energy projects, specializing in distributed and community solar initiatives throughout Canada and the U.S., offered insights into the company’s operations, strategy, and unique competitive position during a recent interview on IBN’s GotStocks podcast (https://ibn.fm/UCIdQ). The conversation centered on SolarBank’s dual role as both a developer and long-term owner of solar energy assets, an approach that differentiates the firm in a competitive market.

“SolarBank is both a developer and an independent power producer,” Lu said. The company identifies suitable sites, secures permits, engages utilities, and finances projects. “As a developer, we secure sites for clean and renewable energy project development. We bring the projects to the attention of local utilities, making sure that we have great interconnection, and we work with local authorities and communities to get these projects permitted. Then, we work to put financing together. That’s the developer’s job.”

Unlike many developers who sell assets post-permitting, SolarBank continues through construction and operations, maintaining a long-term relationship with the asset.

Lu cited key clients such as Honeywell, Qcells, and True Green Capital as examples of SolarBank’s operations and maintenance partnerships. The company has built a $184 million asset base since going public in 2023, generating recurring revenue streams from its portfolio.

What sets SolarBank apart, Lu emphasized, is its vertically integrated model. Most clean energy developers in North America offload assets after development, leaving construction and maintenance to third parties. SolarBank, by contrast, manages every stage from concept to ownership. “When I started SolarBank more than 10 years ago, I decided to create a true ‘A-Z’ one-stop team to develop, build, operate and own those assets. That gives us quite a few advantages,” Lu said. “We do not decide electricity price, regulators do. So, if we want to be profitable, there are only two things to do: increase productivity or reduce cost. Vertical integration allows us to control the focus, the speed, and the simplicity of every step to deliver value to our investors.”

The CEO also pointed to SolarBank’s supply chain flexibility as a way to maintain margins amid rising solar equipment tariffs. While many companies depend on Chinese suppliers, SolarBank has sourced primarily from Southeast Asia since its founding. Recently, it has favored equipment from Indonesia, and Lu indicated that U.S. suppliers may become part of the mix. “Now we’re actually looking at maybe buying U.S. products,” he explained, adding that this supply chain flexibility is how the company has managed to make sure to get the best value for its investors.

Lu also highlighted the experience of his leadership team, which collectively brings over a century of clean energy expertise. That, coupled with a vertically integrated model and diversified sourcing, offers what can be described as an unusually stable foundation for future growth.

SolarBank’s evolving strategy includes a transition from pure project development toward long-term asset ownership. This allows the company to benefit from stable, predictable returns over decades. Its long-term revenue model was further underscored by a recently announced up to $100 million financing with CIM Group to fund the construction of up to 97 megawatts of community solar projects in the United States (https://ibn.fm/JqMv7).

The transaction supports SolarBank’s continued development of distributed solar power projects, systems typically located close to end users and connected to local utilities. These projects play an important role in expanding renewable energy access and support policy goals at the state and federal levels in both Canada and the U.S.

During the interview, Lu expressed confidence in the company’s long-term financial sustainability. “When you’re working with visionary companies like CIM, and when you have a company like SolarBank, I would say that in the foreseeable future, you will have a quite sizable recurring revenue for 25–35 years,” he said.

For more information, visit the company’s website at SolarBankCorp.com.

This report contains forward looking information. Please refer to the press release entitled “US$100 Million Transformative, Project Financing Announced by SolarBank and CIM Group to Fund 97 MW of Renewable Energy Assets in the United States” for additional details on the statements, risks and assumptions. There are several risks associated with the transaction and development of the projects. The development of any project is subject to receipt of interconnection approval, receipt of a community solar contract, required permits, the continued availability of third-party financing arrangements for the Company and the risks associated with the construction of a solar power project. In addition, governments may revise, reduce or eliminate incentives. The transaction is subject to the execution of definitive documentation. SolarBank will also need to secure the financing required to develop the projects to mechanical completion and substantial completion, as prior to such milestone none of the funding from the transaction will be available.

NOTE TO INVESTORS: The latest news and updates relating to SUUN are available in the company’s newsroom at https://ibn.fm/SUUN